{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:57:33Z","timestamp":1792760253325,"version":"4.5.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5509,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1046\/j.1365-2133.2000.03664.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:29:37Z","timestamp":1047360577000},"page":"365-372","source":"Crossref","is-referenced-by-count":348,"title":["Randomized double-blind study of cyclosporin in chronic \u2018idiopathic\u2019 urticaria"],"prefix":"10.1093","volume":"143","author":[{"given":"C.E.H.","family":"Grattan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.F.","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Seed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kobza Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Greaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1523-1747.ep12338544","article-title":"Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria","volume":"106","author":"Niimi","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB2","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","article-title":"Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria","volume":"328","author":"Hide","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0091-6749(96)70230-0","article-title":"Characteristics of histamine-releasing activity in the sera of patients with chronic idiopathic urticaria","volume":"98","author":"Zweiman","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0091-6749(97)70071-X","article-title":"Assessment of autoimmunity in patients with chronic urticaria","volume":"99","author":"Tong","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0091-6749(98)70176-9","article-title":"Comparative studies of functional and binding assays for IgG anti-Fc\u03b5RI\u03b1 (\u03b1-subunit) in chronic urticaria","volume":"101","author":"Ferrer","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-Fc\u03b5RI\u03b1 autoantibodies in autoimmune disorders. Identification of a structure-function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1365-2133.1999.02707.x","article-title":"The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria","volume":"140","author":"Sabroe","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB8","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.144.10.3891","article-title":"Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin","volume":"144","author":"Cirillo","year":"1990","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/1523-1747.ep12499960","article-title":"Anti-inflammatory effect of cyclosporin A on human skin mast cells","volume":"98","author":"Stellato","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB10","first-page":"273","article-title":"Treatment of severe, chronic urticaria with cyclosporin A","volume":"3","author":"Barlow","year":"1993","journal-title":"Eur J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1997.tb00996.x","article-title":"Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria","volume":"52","author":"Toubi","year":"1997","journal-title":"Allergy"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB12","first-page":"309","article-title":"La ciclosporina A nel trattamento dell\u2019orticaria cronica idiopatica severa. Studio clinico su otto casi","volume":"2","author":"Vena","year":"1993","journal-title":"Boll Dermatol Allergol Profess"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB13","first-page":"113","article-title":"Trattamento del\u2019orticaria cronica: chetotifene versus cetirizina in schema sequenziale con ciclosporina A","volume":"11","author":"Curatoli","year":"1996","journal-title":"Boll Dermatol Allergol Profess"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/sim.4780111304","article-title":"Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design","volume":"11","author":"Frison","year":"1992","journal-title":"Stat Med"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/sim.4780080410","article-title":"Covariate imbalance and random allocation in clinical trials","volume":"8","author":"Senn","year":"1989","journal-title":"Stat Med"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB16","volume-title":"Statistical Methods for Rates and Proportions","author":"Fleiss","year":"1981"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB17","volume-title":"Evidence-Based Medicine: How to Practise and Teach EBM.","author":"Sackett","year":"1996"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1365-2133.1998.02319.x","article-title":"A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis","volume":"139","author":"Koo","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2133.1991.tb03280.x","article-title":"Cyclosporin A in atopic dermatitis: therapeutic response is dissociated from effects on allergic reactions","volume":"124","author":"Munro","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB20","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.154.3.1391","article-title":"Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse","volume":"154","author":"Wershil","year":"1995","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2133.2000.03664.x-BIB21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-6147(94)90043-4","article-title":"Mechanisms of inhibition by cyclosporin A on pulmonary leukocyte accumulation","volume":"15","author":"Chapman","year":"1994","journal-title":"Trends Pharmacol Sci"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.2000.03664.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2000.03664.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T04:39:05Z","timestamp":1682051945000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/143\/2\/365\/6687994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03664.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}